Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9241 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.898 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8874 |
High Similarity |
NPD7411 |
Suspended |
0.871 |
High Similarity |
NPD7075 |
Discontinued |
0.8701 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD7819 |
Suspended |
0.863 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.863 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD3750 |
Approved |
0.8571 |
High Similarity |
NPD6801 |
Discontinued |
0.8571 |
High Similarity |
NPD1549 |
Phase 2 |
0.8526 |
High Similarity |
NPD7768 |
Phase 2 |
0.8493 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8472 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8471 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8442 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8435 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8411 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8397 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8389 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8389 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8356 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8333 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8289 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8288 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8288 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8247 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8243 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8243 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8239 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8231 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8207 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8207 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8205 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8165 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8146 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8129 |
Intermediate Similarity |
NPD920 |
Approved |
0.8117 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8113 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8112 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8112 |
Intermediate Similarity |
NPD2797 |
Approved |
0.811 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8105 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8067 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8067 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8042 |
Intermediate Similarity |
NPD3225 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7945 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7927 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7904 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7902 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7888 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7881 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7881 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7862 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7862 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7857 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.784 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7831 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7829 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7824 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7798 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7765 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD919 |
Approved |
0.7738 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7719 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7718 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7702 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7662 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7661 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7628 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7616 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7578 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7557 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7534 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7532 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7484 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7484 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7484 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7484 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7438 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7412 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7399 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7396 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7396 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD943 |
Approved |
0.7374 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD411 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7362 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7348 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7348 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7338 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7338 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD17 |
Approved |
0.7325 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7303 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7233 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7226 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7167 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7114 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7107 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7083 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7056 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7053 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7052 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7044 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7044 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7037 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7024 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6502 |
Phase 2 |
0.7005 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1201 |
Approved |
0.6995 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6995
|
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |